Corlanor
Heart Failure, Systolic, Coronary Disease, Congestive Heart Failure + 5 more
Treatment
2 FDA approvals
10 Active Studies for Corlanor
Treatment for
Heart Failure, Systolic
What is Corlanor
Ivabradine
The Generic name of this drug
Treatment Summary
Ivabradine, also known by the brand name Corlanor, is a medication used to reduce heart rate and treat stable angina pectoris and chronic heart failure. It was approved by the FDA in 2015 and is now also used to treat symptomatic heart failure from dilated cardiomyopathy in patients over 6 months old. Ivabradine works by blocking a specific channel in the sinoatrial node, causing a slower heart rate and more blood flow to the heart muscle. It is generally preferred over other heart rate-lowering drugs due to its lower risk of side effects.
Corlanor
is the brand name
Corlanor Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Corlanor
Ivabradine
2015
4
Approved as Treatment by the FDA
Ivabradine, also known as Corlanor, is approved by the FDA for 2 uses which include Left Ventricular Dysfunction and Ventricular Dysfunction, Left .
Left Ventricular Dysfunction
Helps manage Left Ventricular Dysfunction
Ventricular Dysfunction, Left
Helps manage Left Ventricular Dysfunction
Effectiveness
How Corlanor Affects Patients
Ivabradine works by opening a type of channel (If) during the heart's resting phase and closing it during the active phase, so the effects of ivabradine are based on the heart rate. It will lower the heart rate in a linear, dose-dependent way, meaning that higher doses result in a greater effect. The maximum effective dose is 30-40mg and taking a higher dose will not cause serious sinus bradycardia. Additionally, the metabolite of ivabradine also helps to lower heart rate, contributing to its overall effect.
How Corlanor works in the body
Ivabradine works by slowing down the heart rate through a process called diastolic depolarization. It does this by blocking a type of ion channel called "funny channels" in the heart. This doesn't affect any of the other ion channels in the heart, and it works by attaching to the channel pore from the inside of the cell. By doing this, ivabradine disrupts the flow of ions, which in turn slows down the pacemaker activity in the sinoatrial node, reducing the heart rate and decreasing the demand for oxygen in the heart muscle. As a result, people taking ivab
When to interrupt dosage
The proposed dosage of Corlanor is contingent on the detected disorder, for example Chronic Stable Angina Pectoris, chronic, stable, symptomatic Heart Failure and Congestive Heart Failure. The measure of dosage is also governed by the technique of delivery (e.g. Tablet, film coated or Tablet, film coated - Oral) indicated in the table below.
Condition
Dosage
Administration
Heart Failure, Systolic
5.0 mg, , 7.5 mg, 5.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
chronic, stable, symptomatic Heart Failure
5.0 mg, , 7.5 mg, 5.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
Coronary Disease
5.0 mg, , 7.5 mg, 5.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
Congestive Heart Failure
5.0 mg, , 7.5 mg, 5.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
Ventricular Dysfunction, Left
5.0 mg, , 7.5 mg, 5.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
Cardiomyopathy, Dilated
5.0 mg, , 7.5 mg, 5.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
Angina, Stable
5.0 mg, , 7.5 mg, 5.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
Pharmacotherapy
5.0 mg, , 7.5 mg, 5.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
Warnings
Corlanor Contraindications
Condition
Risk Level
Notes
heart rate
Do Not Combine
Severe Hepatic Impairment
Do Not Combine
Atrioventricular Block
Do Not Combine
Sinoatrial Block
Do Not Combine
Pulse Frequency
Do Not Combine
Pacemaker Dependence
Do Not Combine
Sick Sinus Syndrome
Do Not Combine
Hypotension
Do Not Combine
Heart Failure
Do Not Combine
There are 20 known major drug interactions with Corlanor.
Common Corlanor Drug Interactions
Drug Name
Risk Level
Description
Deutetrabenazine
Major
The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Deutetrabenazine.
Flupentixol
Major
The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Flupentixol.
Glasdegib
Major
The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Glasdegib.
Hydroxyzine
Major
The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Hydroxyzine.
Ivosidenib
Major
The risk or severity of QTc prolongation can be increased when Ivabradine is combined with Ivosidenib.
Corlanor Toxicity & Overdose Risk
Taking ivabradine while pregnant could be toxic to the unborn baby and cause birth defects. Animal studies have found that ivabradine can be harmful to a developing fetus. Women should use effective contraception while taking this drug.
Corlanor Novel Uses: Which Conditions Have a Clinical Trial Featuring Corlanor?
20 active clinical trials are investigating the potential of Corlanor for alleviating chronic, stable, symptomatic Heart Failure, Cardiomyopathy, Dilated and Systolic Dysfunction.
Condition
Clinical Trials
Trial Phases
Angina, Stable
0 Actively Recruiting
Heart Failure, Systolic
0 Actively Recruiting
Coronary Disease
1 Actively Recruiting
Not Applicable
Cardiomyopathy, Dilated
3 Actively Recruiting
Not Applicable, Phase 1
chronic, stable, symptomatic Heart Failure
0 Actively Recruiting
Ventricular Dysfunction, Left
0 Actively Recruiting
Congestive Heart Failure
6 Actively Recruiting
Not Applicable, Phase 2, Phase 3
Pharmacotherapy
0 Actively Recruiting
Corlanor Reviews: What are patients saying about Corlanor?
5
Patient Review
5/7/2019
Corlanor for inappropriate sinus tachycardia
5
Patient Review
3/1/2020
Corlanor for inappropriate sinus tachycardia
5
Patient Review
4/16/2021
Corlanor for inappropriate sinus tachycardia
5
Patient Review
11/3/2021
Corlanor for inappropriate sinus tachycardia
5
Patient Review
6/4/2016
Corlanor for Chronic Heart Failure
5
Patient Review
8/17/2018
Corlanor for inappropriate sinus tachycardia
4.7
Patient Review
4/5/2018
Corlanor for Chronic Heart Failure
4.3
Patient Review
10/31/2015
Corlanor for Chronic Heart Failure
4
Patient Review
8/22/2016
Corlanor for Chronic Heart Failure
Patient Q&A Section about corlanor
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the drug Corlanor used for?
"Corlanor lowers the heart rate for people with chronic heart failure."
Answered by AI
What does Corlanor do for the heart?
"Corlanor is a medication that is used to slow down the heart rate by affecting the electrical activity of the heart. It is used in adults with chronic heart failure, in order to lower the risk of being hospitalized when symptoms worsen."
Answered by AI
What are the side effects of Corlanor?
"The following side effects have been reported by adults during Corlanor's post-approval use: fainting, low blood pressure, a type of irregular heart beat called torsade de pointes, sudden uncontrolled whole-body shaking (ventricular fibrillation), a fast heart rate (ventricular tachycardia), swelling under the skin (angioedema), redness of the skin (erythema), rash, itching (pruritus), hives (urticaria), dizziness (vertigo), and double vision (diplopia), as well as visual impairment."
Answered by AI
What type of drug is Corlanor?
"Corlanor is a class of hyperpolarization-activated cyclic nucleotide-gated channel blockers that was FDA-approved in 2015. It helps to slow the heart rate, and has less effect on lowering blood pressure than other medications designed for the same purpose such as beta blockers."
Answered by AI